Evidence map›Paper›PMID 37512983›Full record

ArticleMicroorganisms2023

Ioannis Andrianopoulos, Theodora Maniatopoulou, Nikolaos Lagos, Nikolaos Kazakos, Athanasios Papathanasiou, Georgios Papathanakos, Despoina Koulenti, Christos Kittas, Vasilios Koulouras

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Impact of Pathogen Status on Sepsis-Associated Acute Respiratory Distress Syndrome Outcomes.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  2. Article
  3. Co-Administration of High-Dose Nebulized Colistin forAntibiotics (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ioannis AndrianopoulosIntensive Care Unit, University Hospital of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0001-9609-2728
Theodora ManiatopoulouIntensive Care Unit, University Hospital of Ioannina, 45500 Ioannina, Greece.
Nikolaos LagosIntensive Care Unit, University Hospital of Ioannina, 45500 Ioannina, Greece.
Nikolaos KazakosIntensive Care Unit, University Hospital of Ioannina, 45500 Ioannina, Greece.
Athanasios PapathanasiouIntensive Care Unit, University Hospital of Ioannina, 45500 Ioannina, Greece.
Georgios PapathanakosIntensive Care Unit, University Hospital of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0003-2521-5326
Despoina KoulentiUQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4029, Australia.ORCID 0000-0003-4364-2612
Christos KittasDepartment of Microbiology, University Hospital of Ioannina, 45500 Ioannina, Greece.ORCID 0000-0002-6458-897X
Vasilios KoulourasIntensive Care Unit, University Hospital of Ioannina, 45500 Ioannina, Greece.
University Hospital of Ioannina · GRThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease (COVID-19) pandemic increased the incidence of severe infections caused by multidrug-resistant (MDR) pathogens among critically ill patients, such as

Indexed as

Acinetobacter baumanniibloodstream infectionsCOVID-19critically illintensive care unitmultidrug-resistant pathogenssepsisventilator-associated pneumonia

Identifiers

PMID37512983
PMCPMC10383443
OpenAlexW4384525884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.